Anti-inflammatory factors present in ALS and UCS, such as TGF-β and IL-1RA, can effectively suppress chronic inflammation on the ocular surface and reduce the detrimental impact of inflammatory mediators on tear film stability. This evidence concerns the gene TGFB1 and amyotrophic lateral sclerosis.